79064056 - IQA

Information

  • Trademark
  • 79064056
  • Serial Number
    79064056
  • Filing Date
    June 10, 2008
    16 years ago
  • Transaction Date
    June 18, 2019
    5 years ago
  • Status Date
    June 10, 2018
    6 years ago
  • Location Date
    January 14, 2010
    14 years ago
  • Status Code
    402
  • Current Location
    TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    LEE, DEBRA ANN
  • Law Office Assigned Location Code
    M70
  • Owners
Mark Drawing Code
4000
Mark Identification
IQA
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; bacterial, chemical, and biological preparations for medical and veterinary purposes, namely, for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; chemico-pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; herbal teas for medicinal purposes, medicinal herbs, drugs for medical purposes, namely for the treatment of immunity disorders, skin disorders; diagnostic preparations for medical and veterinary purposes, fumigating preparations, namely insecticides, pesticides, fungicides and herbicides; enzyme preparations, namely, improving inflamatory disorders; chemical preparations for analysing DNA for medical purposes, bacteriological cultures media, vitamins for medical and veterinary purposes, antibiotics for the treatment of diseases caused by gram-positive and gram-negative pathogens; amino acids for medical purposes, analgesics, anesthetics, namely for non-surgical use; cotton swabs for medical purposes, balms for medical purposes, albuminous foodstuffs specially adapted for medical purposes, diabetic sugar for medical purposes, suppositories for the treatment of pain; dietetic food and drinks adapted for medical use; hormones for medical purposes, capsules sold empty for medicines, first-aid boxes being first-aid kits, ointments for medical purposes for the treatment of skin disorders; adhesive plasters for topical application of drugs; isotopes, namely, radio-isotope markers for therapeutic or diagnostic use; super-oxidised water, radioactive substances, namely, diagnostic radiopharmaceutical preparations; radium, namely, as a component of radio-isotope markers for therapeutic or diagnostic use; esters, namely, as antihyperlipoproteinic drugs; tablets for the treatment of proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; hemoglobin, herbicides, anesthetics, namely, chloroform; antiseptic, namely, iodoform, medicated jujube for the treatment of skin disorders; blood plasma, lactose, for use as a dietary supplement; opiates for the treatment of sleep disturbances; purgatives; insecticides
  • GS0421: Research and development in the field of pharmacy and medicine for others, research relating to healthcare, science and technology in the field of pharmacy, medicine, biotechnologies, chemistry; clinical, medical and scientific research, expert analysis in medicine, pharmacy, veterinary medicine, biological, bacteriological and chemical research, pharmaceutical testing; development and studies in the field(s) of chemistry, biochemistry, pharmacology, medicine, biotechnologies; quality control for others; medicalphysical, physical-chemical and chemical testing of medicines including tests relating to storing samples for faster, more sustainable, reliable studies; cosmetics research, expertise, namely, consultation and analysis concerning safety of used compounds; development of new technologies in the field(s) of chemistry analysis; scientific technical analysis; testing and measuring services relating to chemical and physical stability of drugs and chemical compounds, biosimilarity of drugs, bioequivalence of drugs; material testing, consultancy relating to biochemistry, development of computer hardware and software, medical laboratory research services; pharmaceutical discovery services, namely, pharmaceutical research; development of pharmaceutical compositions, chemical analysis, physics research, geological surveys, pharmaceutical clinical studies using web databases, design of computer systems and construction of Internet sites in the field of pharmacy; consultancy in the fields of computer applications and information technology; rental of software; installation, repair, maintenance and servicing of software; creation of interactive applications enabling the transfer and creation of graphic images using the Internet; software design, creation and maintenance of web pages for clients; hosting of web pages; installation of computer programs, computer system design, Internet database system and Internet application programming; updating and maintenance of computer programs, duplication of computer programs, technical studies in the field of computers and software; graphic arts designing; consultancy in the field of computer and information technology
  • TLIT00: The transliteration of the non-Latin characters in the mark is: OQA.
Case File Event Statements
  • 3/15/2019 - 5 years ago
    35 - UNDELIVERABLE MAIL - NO ACTION TAKEN Type: UNDN
  • 1/11/2019 - 5 years ago
    34 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENA
  • 1/10/2019 - 5 years ago
    33 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 2/5/2011 - 13 years ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 1/14/2011 - 13 years ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/14/2011 - 13 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/23/2010 - 13 years ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 7/8/2010 - 14 years ago
    28 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/8/2010 - 14 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 1/14/2010 - 14 years ago
    26 - ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE Type: MAB0
  • 1/14/2010 - 14 years ago
    25 - ABANDONMENT - INCOMPLETE RESPONSE Type: ABN0
  • 6/12/2009 - 15 years ago
    24 - NOTICE OF UNRESPONSIVE AMENDMENT - MAILED Type: NAUD
  • 6/11/2009 - 15 years ago
    23 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED Type: NAUD
  • 5/13/2009 - 15 years ago
    22 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 5/13/2009 - 15 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/11/2009 - 15 years ago
    20 - PAPER RECEIVED Type: MAIL
  • 4/10/2009 - 15 years ago
    19 - NOTICE OF UNRESPONSIVE AMENDMENT - MAILED Type: NAUD
  • 4/10/2009 - 15 years ago
    18 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED Type: NAUD
  • 3/24/2009 - 15 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/24/2009 - 15 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/24/2009 - 15 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/18/2009 - 15 years ago
    14 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 3/18/2009 - 15 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/16/2009 - 15 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 3/13/2009 - 15 years ago
    11 - PAPER RECEIVED Type: MAIL
  • 3/14/2009 - 15 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/17/2009 - 15 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/17/2009 - 15 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/14/2009 - 15 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/13/2009 - 15 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/11/2009 - 15 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/10/2009 - 15 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/6/2009 - 15 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/6/2009 - 15 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/5/2009 - 15 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR